# US 2025/0166723 A1 · Machine learning applications to predict biological outcomes and elucidate underlying biological mechanisms

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0166723 A1
- Document ID: US20250166723A1
- Status: Published application
- Kind: A1
- Application number: 18/841,319
- Filed: 2023-02-24
- Published: 2025-05-22
- Earliest claimed: 2022-02-25
- Assignees: Fred Hutchison Cancer Center
- Applicants: Fred Hutchison Cancer Center
- Inventors: Taranjit Gujral; Siddharth Vijay
- Web page: https://patentgrep.com/patent/US20250166723A1

## CPC

- G06N 3/0985: Hyperparameter optimisation; Meta-learning; Learning-to-learn
- G16B 5/00: ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B 15/30: Drug targeting using structural data; Docking or binding prediction
- G16B 25/10: Gene or protein expression profiling; Expression-ratio estimation or normalisation
- G16B 40/20: Supervised data analysis
- G16H 50/50: for simulation or modelling of medical disorders
- G06N 3/044: Recurrent networks, e.g. Hopfield networks
- G06N 3/0464: Convolutional networks [CNN, ConvNet]
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16H 20/00: ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Systems and methods for modeling highly complex biological relations in machine-learned models, such as neural networks (e.g., such as deep neural networks (DNNs)), to predict biological outcomes and elucidate underlying mechanisms are described. The systems and methods utilize recursive feature elimination and scoring and can be utilized to prioritize particular compounds or treatments for clinical development and direct new avenues of research and development based on elucidated mechanisms.

## Claims

### Claim 1

A method comprising:
receiving a training data set comprising a set of biological input features and an observed response of a biological system to the set of biological input features or a treatment or therapy applied to the biological system;
training, based at least in part on the training data set, a model to predict a response of the biological system to the set of biological input features;
determining a baseline error associated with the model based at least in part on a first difference between a predicted response determined by the model and the observed response of the biological system;
determining permuted input data by altering a first feature of the set of biological input features;
determining, by the model and based at least in part on the permuted input data, an updated prediction of the biological system to the permuted input data;
determining a permutation error associated with the updated prediction based at least in part on a second difference between the updated prediction and the observed response;
determining an importance score associated with the first feature based at least in part on a difference between the baseline error and the permutation error;
determining, based at least in part on the importance score and one or more importance score associated with one or more other input features of the set of biological input features, a ranking of the first input feature within the set of biological input features; and
determining, based at least in part on the ranking, a subset of biological input features from the set of biological input features.

### Claim 2 (depends on 1)

The method of claim 1, wherein:
the set of biological input features is a first set associated with a first biological sample;
the method further comprises receiving a second set of biological input features associated with a second biological sample; and
determining the permuted input data comprises exchanging a first portion of the first set with a second portion of the second set.

### Claim 3 (depends on 1, 2)

The method of either claim 1 or 2, wherein the model is a neural network and training the model comprises:
determining, by the model and based at least in part on the set of biological input features, an estimated response of the biological system;
determining a loss based at least in part on a third difference between the estimated response and the observed response of the biological system; and
altering one or more parameters of a component of the model to reduce the loss.

### Claim 4 (depends on 3)

The method of claim 3, wherein training the model further includes determining one or more hyperparameters associated with the model, the hyperparameters including at least one of:
an epoch;
a batch size;
an optimizer algorithm type;
an initial weighting scheme;
a hidden layer quantity;
a number of nodes per hidden layer;
a number of layers containing one or more dropouts;
a percentage of dropouts in a layer that includes dropouts; or
an activation function type.

### Claim 5 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein the first input feature includes an activity profile associated with at least one of:
a small molecule;
a kinase inhibitor;
a protein;
a biomarker;
an RNA sequence; and
a DNA sequence.

### Claim 6 (depends on 5)

The method of claim 5, wherein the activity profile quantifies an extent to which an input feature acts upon a molecular pathway or molecular mechanism or a extent to which the input feature influences a response of the biological system to a treatment or therapy.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The method of any one of claims 1-6, wherein the first input feature includes at least one of:
a small molecule;
a kinase inhibitor;
a protein;
a biomarker;
an RNA sequence; and
a DNA sequence.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The method of any one of claims 1-7, wherein determining the subset of biological input features from the set of biological input features comprises determining that the subset of biological input features is associated with a top r percentage of the set of biological input features by importance score ranking.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method of any one of claims 1-8, wherein the observed response of the biological system comprises one of:
a quantified viability of a cell;
an immune checkpoint therapy response; or
an immune response to inoculation.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The method of any one of claims 1-9, wherein the set of biological input features comprises different kinases, kinase inhibitors, or activity profiles associated with different kinases or kinase inhibitors.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of any one of claims 1-10, wherein the observed response of the biological system includes a viability of at least one of an epithelial or mesenchymal cancer cell or a response to ICB therapy.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The method of any one of claims 1-11, wherein the model is a neural network and training the model comprises:
determining, by the model and based at least in part on the set of biological input features, an estimated response of the biological system;
determining a loss based at least in part on a third difference between the estimated response and the observed response of the biological system; and
altering one or more parameters of a component of the model to reduce the loss.

### Claim 13

A system comprising:
one or more processors; and
a memory storing processor-executable instructions that, when executed by the one or more processors, cause the system to perform operations comprising:
receiving a training data set comprising a set of biological input features and an observed response of a biological system associated with the set of biological input features;
training, based at least in part on the training data set, a model to predict a response of the biological system to the set of biological input features;
determining a baseline error associated with the model based at least in part on a first difference between a predicted response determined by the model and the observed response of the biological system;
determining permuted input data by altering a first feature of the set of biological input features;
determining, by the model and based at least in part on the permuted input data, an updated prediction of the biological system to the permuted input data;
determining a permutation error associated with the updated prediction based at least in part on a second difference between the updated prediction and the observed response;
determining an importance score associated with the first feature based at least in part on a difference between the baseline error and the permutation error;
determining, based at least in part on the importance score and one or more importance score associated with one or more other input features of the set of biological input features, a ranking of the first input feature within the set of biological input features; and
determining, based at least in part on the ranking, a subset of biological input features from the set of biological input features.

### Claim 14 (depends on 13)

The system of claim 13, wherein the model is a neural network and training the model comprises:
determining, by the model and based at least in part on the set of biological input features, an estimated response of the biological system;
determining a loss based at least in part on a third difference between the estimated response and the observed response of the biological system; and
altering one or more parameters of a component of the model to reduce the loss.

### Claim 15 (depends on 13, 14)

The system of either claim 13 or 14, wherein training the model further includes determining one or more hyperparameters associated with the model, the hyperparameters including at least one of:
an epoch;
a batch size;
an optimizer algorithm type;
an initial weighting scheme;
a hidden layer quantity;
a number of nodes per hidden layer;
a number of layers containing one or more dropouts;
a percentage of dropouts in a layer that includes dropouts; or
an activation function type.

### Claim 16 (depends on 13, 14, 15)

The system of any one of claims 13-15, wherein the first input feature includes an activity profile associated with at least one of:
a small molecule;
a kinase inhibitor;
a protein;
a biomarker;
an RNA sequence; and
a DNA sequence.

### Claim 17 (depends on 16)

The system of claim 16, wherein the activity profile quantifies an extent to which an input feature acts upon a molecular pathway or molecular mechanism.

### Claim 18 (depends on 13, 14, 15, 16, 17)

The system of any one of claims 13-17, wherein the first input feature includes at least one of:
a small molecule;
a kinase inhibitor;
a protein;
a biomarker;
an RNA sequence; and
a DNA sequence.

### Claim 19 (depends on 13, 14, 15, 16, 17, 18)

The system of any one of claims 13-18, wherein determining the subset of biological input features from the set of biological input features comprises determining that the subset of biological input features is associated with a top r percentage of the set of biological input features by importance score ranking.

### Claim 20 (depends on 13, 14, 15, 16, 17, 18, 19)

The system of any one of claims 13-19, wherein the observed response of the biological system comprises one of:
a quantified viability of a cell;
an immune checkpoint therapy response; or
an immune response to inoculation.

### Claim 21 (depends on 13, 14, 15, 16, 17, 18, 19, 20)

The system of any one of claims 13-20, wherein the set of biological input features comprises different kinases, kinase inhibitors, or activity profiles associated with different kinases or kinase inhibitors.

### Claim 22 (depends on 13, 14, 15, 16, 17, 18, 19, 20, 21)

The system of any one of claims 13-21, wherein the observed response of the biological system includes a viability of at least one of an epithelial or mesenchymal cancer cell.

### Claim 23 (depends on 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The system of any one of claims 13-22, wherein the set of biological input features comprises a plurality of RNA loci.

### Claim 24 (depends on 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)

The system of any one of claims 13-23, wherein the observed response of the biological system includes a response to ICB therapy, a pharmaceutical treatment or administration, or a therapy applied to the biological system.

### Claim 25 (depends on 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The system of any one of claims 13-24, wherein the model is a neural network and training the model comprises:
determining, by the model and based at least in part on the set of biological input features, an estimated response of the biological system;
determining a loss based at least in part on a third difference between the estimated response and the observed response of the biological system; and
altering one or more parameters of a component of the model to reduce the loss.

### Claim 26 (depends on 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The system of any one of claims 13-25, wherein:
the set of biological input features is a first set associated with a first biological sample;
the operations further comprise receiving a second set of biological input features associated with a second biological sample; and
determining the permuted input data comprises exchanging a first portion of the first set with a second portion of the second set.

### Claim 27

A non-transitory computer-readable medium comprising computer-executable instructions that, when executed by one or more processors, cause the one or more processors to perform operations comprising:
receiving a training data set comprising a set of biological input features and an observed response of a biological system to the set of biological input features;
training, based at least in part on the training data set, a model to predict a response of the biological system to the set of biological input features;
determining a baseline error associated with the model based at least in part on a first difference between a predicted response determined by the model and the observed response of the biological system;
determining permuted input data by altering a first feature of the set of biological input features;
determining, by the model and based at least in part on the permuted input data, an updated prediction of the biological system to the permuted input data;
determining a permutation error associated with the updated prediction based at least in part on a second difference between the updated prediction and the observed response;
determining an importance score associated with the first feature based at least in part on a difference between the baseline error and the permutation error;
determining, based at least in part on the importance score and one or more importance score associated with one or more other input features of the set of biological input features, a ranking of the first input feature within the set of biological input features; and
determining, based at least in part on the ranking, a subset of biological input features from the set of biological input features.

### Claim 28 (depends on 27)

The non-transitory computer-readable medium of claim 27, wherein the model is a neural network and training the model comprises:
determining, by the model and based at least in part on the set of biological input features, an estimated response of the biological system;
determining a loss based at least in part on a third difference between the estimated response and the observed response of the biological system; and
altering one or more parameters of a component of the model to reduce the loss.

### Claim 29 (depends on 27, 28)

The non-transitory computer-readable medium of either claim 27 or 28, wherein training the model further includes determining one or more hyperparameters associated with the model, the hyperparameters including at least one of:
an epoch;
a batch size;
an optimizer algorithm type;
an initial weighting scheme;
a hidden layer quantity;
a number of nodes per hidden layer;
a number of layers containing one or more dropouts;
a percentage of dropouts in a layer that includes dropouts; or
an activation function type.

### Claim 30 (depends on 27, 28, 29)

The non-transitory computer-readable medium of any one of claims 27-29, wherein the first input feature includes an activity profile associated with at least one of:
a small molecule;
a kinase inhibitor;
a protein;
a biomarker;
an RNA sequence; and
a DNA sequence.

### Claim 31 (depends on 30)

The non-transitory computer-readable medium of claim 30, wherein the activity profile quantifies an extent to which an input feature acts upon a molecular pathway or molecular mechanism.

### Claim 32 (depends on 27, 28, 29, 30, 31)

The non-transitory computer-readable medium of any one of claims 27-31, wherein the first input feature includes at least one of:
a small molecule;
a kinase inhibitor;
a protein;
a biomarker;
an RNA sequence; and
a DNA sequence.

### Claim 33 (depends on 27, 28, 29, 30, 31, 32)

The non-transitory computer-readable medium of any one of claims 27-32, wherein determining the subset of biological input features from the set of biological input features comprises determining that the subset of biological input features is associated with a top r percentage of the set of biological input features by importance score ranking.

### Claim 34 (depends on 27, 28, 29, 30, 31, 32, 33)

The non-transitory computer-readable medium of any one of claims 27-33, wherein the observed response of the biological system comprises one of:
a quantified viability of a cell;
an immune checkpoint therapy response; or
an immune response to inoculation.

### Claim 35 (depends on 27, 28, 29, 30, 31, 32, 33, 34)

The non-transitory computer-readable medium of any one of claims 27-34, wherein the set of biological input features comprises different kinases, kinase inhibitors, or activity profiles associated with different kinases or kinase inhibitors.

### Claim 36 (depends on 27, 28, 29, 30, 31, 32, 33, 34, 35)

The non-transitory computer-readable medium of any one of claims 27-35, wherein the observed response of the biological system includes a viability of at least one of an epithelial or mesenchymal cancer cell.

### Claim 37 (depends on 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The non-transitory computer-readable medium of any one of claims 27-36, wherein the set of biological input features comprises a plurality of RNA loci.

### Claim 38 (depends on 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The non-transitory computer-readable medium of any one of claims 27-37, wherein the observed response of the biological system includes a response to ICB therapy.

### Claim 39 (depends on 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The non-transitory computer-readable medium of any one of claims 27-38, wherein the model is a neural network and training the model comprises:
determining, by the model and based at least in part on the set of biological input features, an estimated response of the biological system;
determining a loss based at least in part on a third difference between the estimated response and the observed response of the biological system; and
altering one or more parameters of a component of the model to reduce the loss.

### Claim 40 (depends on 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The non-transitory computer-readable medium of any one of claims 27-39, wherein:
the set of biological input features is a first set associated with a first biological sample;
the operations further comprise receiving a second set of biological input features associated with a second biological sample; and
determining the permuted input data comprises exchanging a first portion of the first set with a second portion of the second set.
